Gapping up
In reaction to strong earnings/guidance: GTAT +23.5% (also announces agreement with AAPL that impacts 2H13 and 2014 Outlooks), ENDP +22.6%, FN +11.5%, (light volume), ACUR +9.8%, (also announces Distribution of Nexafed by Rite Aid Pharmacies), CSU +9.2%, ARCI +8.5%, ORIG +8%, COCO +6.5%, UVE +6.5%, AOL +5.4%, TMUS +5.2%, KERX +5% (also announces Zerenex (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study of Non-Dialysis Dependent Chronic Kidney Disease Patients With Elevated Serum Phosphorus and Iron Deficiency Anemia), HL +4.8%, CSOD +4.5%, CATM +3.5%, (light volume), HTZ +2.9%, CTSH +2.7%, JMBA +2%, (light volume), MRO +1.7%, RKT +1.4%, (light volume), BDX +1.4%, (light volume), CVS +1.3%, PKT +1%, REGN +0.9%, WFT +0.4%, (also names new Chief Financial Officer; appoints new Chief Operating Officer as current operating officer retires), .
Select mining stocks trading higher: BBL +1.9%, RIO +1.8%, BHP +1.5%, GOLD +1.2%.
A few solar names are trading higher: SUNE +4.9% (SunEdison upgraded to Overweight from Neutral at Piper), YGE +4.9%, RSOL +2.9%, TSL +2.3%, CSIQ +1.9%, SOL +1.6%
Other news: CYTX +45.9% ( licenses Asia-Pacific cardiovascular, renal & diabetes markets to Lorem Vascular for up to $531 mln; co to receive $31 mln upfront in equity and initial purchase commitments), ORBC +5.6% (Orbcomm and Inmarsat to form strategic alliance to collaborate on M2M opportunities ), PIP +4.4% (Theraclone Sciences' monocloncal antibody candidate PGT121 suppresses HIV in simian models of disease; Note: On August 1, 2013, Theraclone and PharmAthene announced a definitive merger agreement), LOCK +4% (following positive comments on MadMoney), ALU +3.6% (still checking), NUAN +3.2% (still checking), RBCN +3.2% (following GTAT earnings/news), P +2.5% (may be attributed to CTO comments, also JPM positive), NQ +2.2% (Bloomberg discusses that Muddy Waters may be correct on NQ payments issue, but cash accounting criticism may be incorect ), ECA +2% ( announces vision and strategy; co will focus its capital investment on five oil and liquids-rich resource plays in N. America ), LCC +1.1% (NYTimes discusses that the US is in discussions to settle suit related to AAMRQ/US Airways merger ), CBST +0.6% (Cubist Pharma modestly higher following exec interview on MadMoney), .
Analyst comments: SB +3.3% (Safe Bulkers upgraded to Buy from Neutral at Citigroup), BBRY +1.5% (upgraded to Hold from Sell at Societe Generale, upgraded to Hold from Sell at Deutsche Bank, downgraded to Sector Underperform from Sector Outperform at CIBC Wrld Mkts)